Drug Type Chemical drugs |
Synonyms Ubiquitin specific protease inhibitor (Ellipses Pharma) |
Target |
Action inhibitors |
Mechanism USP inhibitors(Ubiquitin specific peptidases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | United Kingdom | 16 Oct 2024 |